MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer.
J Immunother Cancer
; 10(3)2022 03.
Article
in En
| MEDLINE
| ID: mdl-35292516
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Tumor Microenvironment
/
Head and Neck Neoplasms
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
J Immunother Cancer
Year:
2022
Type:
Article
Affiliation country:
Israel